Fortress Biotech, Inc. (FBIO)

3.63 +0.03 (+0.83%) USD  |  NASDAQ  |  Dec 24, 12:20
More

Fortress Biotech SG&A Expense (TTM): 108.70M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for FBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Journey Medical Corp. 44.56M
Ultragenyx Pharmaceutical, Inc. 343.56M
Axsome Therapeutics, Inc. 514.57M
Apellis Pharmaceuticals, Inc. 524.64M
Absci Corp. 35.27M